The expressions of ITPR2, MDM2, KRAS and CDK4 were also highest in the CLDN2+ AT2 cells (Fig. 3g), and higher in the tumor-derived CLDN2+ AT2 cells than the normal ones (Fig. 3h). The gene discussed is KRAS; the disease is neoplasm.